PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsNippon Shinyaku
Nippon Shinyaku
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
ViltepsoViltolarsen2020-08-122031
Duchenne muscular dystrophy
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Viltolarsen
duchenne muscular dystrophy
,
muscular dystrophies
Aglatimagene besadenovec
neoplasms
,
lymphoma
,
prostatic hyperplasia
,
lower urinary tract symptoms
,
hypertrophy
,
prostatic neoplasms
,
hyperplasia
Sodium chloride
urinary bladder neoplasms
,
non-muscle invasive bladder neoplasms
Sodium lactate
zika virus infection
,
zika virus
,
lyme disease
,
borrelia infections
,
ventilator-associated pneumonia
,
clostridium infections
,
clostridioides difficile
,
virus diseases
,
chikungunya fever
,
encephalitis
,
japanese encephalitis
,
pseudomonas infections
,
chikungunya virus
ILGINATINIB
essential thrombocythemia
,
polycythemia vera
,
primary myelofibrosis
,
thrombocytosis
,
polycythemia
Microcrystalline cellulose
type 2 diabetes mellitus
,
diabetes mellitus
NS-018
essential thrombocythemia
,
polycythemia vera
,
primary myelofibrosis
,
thrombocytosis
,
polycythemia
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use